How Has the Hypertrophic And Keloid Scar Treatment Market Evolved Historically and What is its Current Size?
The hypertrophic and keloid scar treatment market has seen considerable growth due to a variety of factors.
•Over the recent years, there has been a quick surge in the market size of hypertrophic and keloid scar treatment. The market is projected to expand from $7.72 billion in 2024 to $8.51 billion in 2025, growing at a compound annual growth rate (CAGR) of 10.3%.
The increase during the historic phase can be linked to the escalating occurrence of hypertrophic and keloid scars, advancements in scar analysis, widespread usage of topical treatments, surgical and invasive procedures, and patient demand for scar enhancement.
What is the Forecasted Market Size and CAGR for the Hypertrophic And Keloid Scar Treatment Market?
The hypertrophic and keloid scar treatment market is expected to maintain its strong growth trajectory in upcoming years.
• The market for hypertrophic and keloid scar treatments is projected to experience swift expansion in the upcoming years, reaching a worth of $12.51 billion in 2029 with a Compound Annual Growth Rate (CAGR) of 10.1%.
This anticipated surge during the forecast period can be associated with the rise of minimally invasive treatments, advancements in scar correction techniques, a growing interest in combined therapy methods, an increase in early intervention and awareness, as well as global aesthetic tendencies. Critical trends expected throughout this period consist of emerging injectable therapies, consolidated therapy for enhanced results, patient-focused strategies, scar evaluation technologies, and the use of telemedicine for post-treatment follow-ups and consultations.
What Key Factors and Trends are Driving the Growth of the Hypertrophic And Keloid Scar Treatment Market?
The hypertrophic and keloid scar treatment market is poised for growth, primarily driven by an uptick in road mishaps and burn incidents. Such accidents, which occur on the roads involving at least one vehicle and individual, warrant timely and suitable action to prevent them and facilitate effective treatment. Hypertrophic and keloid scar treatments serve to assist those injured in such unfortunate events by reducing the rigidity and height of the resultant scars. Hence, any upward trend in road mishaps and burns boosts the hypertrophic and keloid scar treatment market's growth. For instance, data from the National Highway Traffic Safety Administration, a US federal government agency under the Department of Transportation, reveals that about 9,560 individuals lost their lives in vehicular accidents in the initial three months of 2022, marking nearly a 7% hike from the 8,935 deaths during the corresponding period in 2021. Further, the fatality rate increased from an estimated 1.25 deaths per 100 million vehicle miles in the first quarter of 2021 to 1.27 deaths per 100 million vehicle miles in the first quarter of 2022. Therefore, escalating road accidents and burn cases signal a positive outlook for the hypertrophic and keloid scar treatment market.
What are the Market Segments in the Hypertrophic And Keloid Scar Treatment Market?
The hypertrophic and keloid scar treatment market covered in this report is segmented –
1) By Treatment: Cryotherapy, Surgical Excision, Pressure Dressings, Intralesional 5-Fluorouracil, Superficial X-Ray, Intralesional Corticosteroid Injection, Other Treatments
2) By Products: Topical Products, Laser Products, Injectables, Other Products
3) By Scar: Hypertrophic Scars, Keloid Scars
4) By End-Use: Hospitals, Clinics, Other End-Users
Subsegments:
1) By Cryotherapy: Liquid Nitrogen Cryotherapy, Intralesional Cryotherapy
2) By Surgical Excision: Simple Excision, Excision With Skin Grafting
3) By Pressure Dressings: Elastic Bandage Pressure Dressings, Silicone Gel Pressure Dressings
4) By Intralesional 5-Fluorouracil: Standalone 5-FU Treatment, Combination With Corticosteroids
5) By Superficial X-Ray: Low-Dose X-Ray Therapy, Combination X-Ray With Other Treatments
6) By Intralesional Corticosteroid Injection: Triamcinolone Acetonide Injection, Combination With 5-Fluorouracil
7) By Other Treatments: Laser Therapy, Radiotherapy, Interferon Therapy
Pre-Book The Hypertrophic And Keloid Scar Treatment Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
What Trends are Shaping the Hypertrophic And Keloid Scar Treatment Market?
Top players in the hypertrophic and keloid scar treatment market are concentrating on creating clinically validated silicon-based solutions, such as medical-grade silicone strips, to increase their market earnings. These strips are therapeutic items created from premium silicone material, specifically designed to encourage scar healing and reduction. For example, in April 2023, Scar Erase, a company from the UK specialising in silicone-based scar reduction therapies, introduced its Scar Erase silicone strips, a clinically approved and cost-effective solution for scar treatment. These strips, created from 3mm of medical-grade silicone, assist in the therapy of various scar categories, such as hypertrophic, keloid, post-surgery, and stretch marks. This silicone technology envelops the scar area, encouraging hydration and the perfect healing conditions, hence resulting in notable improvement in the scar's texture, color, and size. It provides a readily available at-home scar treatment solution, whilst ensuring comfort and discreetness.
Who Are the Key Players in the Hypertrophic And Keloid Scar Treatment Market?
Major companies operating in the hypertrophic and keloid scar treatment market include:
• Smith & Nephew plc
• Merz Pharmaceutical LLC
• Lumenis Ltd.
• Enaltus LLC
• Sonoma Pharmaceuticals Inc.
• Molnlycke Health Care AB
• Suneva Medical Inc.
• Pacific World Corporation
• Perrigo Company plc
• Cynosure Inc.
• Alliance Pharma plc
• Newmedical Technology Inc.
• HRA Pharma
• Scar Heal Inc.
• McKesson Medical Surgical Inc.
• Johnson & Johnson Private Limited
• Medtronic plc
• 3M Company
• Sinclair Pharma plc
• Avita Medical
• Stratpharma AG
• Revitol Corporation Inc.
• Scarfade
• Biodermis
• Mederma
• Silagen
What are the Regional Insights into the Hypertrophic And Keloid Scar Treatment Market?
North America was the largest region in the hypertrophic and keloid scar treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global hypertrophic and keloid scar treatment market report during the forecast period. The regions covered in the hypertrophic and keloid scar treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
